Stephan Ladisch, M.D., professor of pediatrics and professor of biochemistry and molecular biology, was featured in Medical Xpress for recently published research in the American Society of Hematology journal, Blood. The international study found that prolonged, intense initial treatment in children with multi-system Langerhans cell histiocytosis (MS-LCH) can achieve survival rates as high as 84 percent—a full 15 percent improvement over his previous clinical trial. This research was also featured in Science Codex.
Medical Xpress - Study Shows Longer Treatment for Children With Langerhans Cell Hystiocytosis Improves Survival Rates
Latest News
The GW School of Medicine and Health Sciences (SMHS) is pleased to announce that Ioannis Koutroulis, MD, PhD, MBA, associate professor of Pediatrics, Emergency Medicine, Genomics and Precision Medicine has been selected to serve as the Associate Dean of the Office of MD Admissions on a permanent…
Lawrence Deyton, MD ’85, MSPH, will be the keynote speaker for the 2024 GW MD Graduation and Diploma Ceremony on May 19, 2024, in Lisner Auditorium.
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) is pleased to announce that Alison Hall, PhD, has been appointed to serve as the Senior Associate Dean for Research.